Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

[Comparison of (18)F-FDG PET/CT and enhancement CT in diagnosing regional lymph node metastasis of colorectal cancer].

Wang XY, Rao LJ, Yi QQ, Chen ZF, Li ZP, Zhang XS, Shi XC, Yi C.

Zhonghua Yi Xue Za Zhi. 2013 Aug 6;93(29):2288-91. Chinese.

PMID:
24300147
2.

Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.

Herbrik M, Treffert J, Geiger B, Riegger C, Hartung V, Rosenbaum-Krumme SJ, Forsting M, Antoch G, Heusner TA.

J Nucl Med. 2011 Oct;52(10):1520-5. doi: 10.2967/jnumed.111.092593. Epub 2011 Sep 9.

3.

Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.

Nakajo M, Nakajo M, Kajiya Y, Jinguji M, Nishimata N, Shimaoka S, Nihara T, Aridome K, Tanaka S, Fukukura Y, Tani A, Koriyama C.

Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1223-32. doi: 10.1007/s00259-013-2424-9. Epub 2013 May 8.

PMID:
23653240
4.

Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.

Riegger C, Koeninger A, Hartung V, Otterbach F, Kimmig R, Forsting M, Bockisch A, Antoch G, Heusner TA.

Acta Radiol. 2012 Dec 1;53(10):1092-8. doi: 10.1258/ar.2012.110635. Epub 2012 Sep 22.

PMID:
23002144
5.

Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer.

Kwak JY, Kim JS, Kim HJ, Ha HK, Yu CS, Kim JC.

World J Surg. 2012 Aug;36(8):1898-905. doi: 10.1007/s00268-012-1575-3.

PMID:
22526032
6.
7.
8.

Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.

Hahn S, Hecktor J, Grabellus F, Hartung V, Pöppel T, Kimmig R, Forsting M, Antoch G, Heusner TA.

Acta Radiol. 2012 Jun 1;53(5):518-23. doi: 10.1258/ar.2012.110420. Epub 2012 Apr 30.

PMID:
22547387
9.

Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.

Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, Cho A, Lee JD.

J Nucl Med. 2005 Oct;46(10):1582-8.

10.

[Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].

Yang WF, Tan GZ, Fu Z, Yu JM.

Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):925-8. Chinese.

PMID:
20193335
11.

[Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].

Hu M, Yu JM, Liu NB, Liu LP, Guo HB, Yang GR, Zhang PL, Xu XQ.

Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):306-9. Chinese.

PMID:
18788639
12.

Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.

Nakajo M, Nakajo M, Jinguji M, Tani A, Kajiya Y, Tanabe H, Fukukura Y, Nakabeppu Y, Koriyama C.

Radiology. 2013 Jun;267(3):891-901. doi: 10.1148/radiol.13121546. Epub 2013 Mar 6.

PMID:
23468571
13.

Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.

Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.

Scand J Urol Nephrol. 2011 Mar;45(2):122-8. doi: 10.3109/00365599.2010.544672. Epub 2011 Jan 13.

PMID:
21231796
14.

Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.

An YS, Lee DH, Yoon JK, Lee SJ, Kim TH, Kang DK, Kim KS, Jung YS, Yim H.

Nuklearmedizin. 2014;53(3):89-94. doi: 10.3413/Nukmed-0605-13-06. Epub 2013 Nov 13.

PMID:
24220324
15.

The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.

Choi WH, Yoo IR, O JH, Kim SH, Chung SK.

Br J Radiol. 2011 Jul;84(1003):593-9. doi: 10.1259/bjr/56324742. Epub 2010 Nov 16.

16.

Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience.

Kim J, Lee J, Chang E, Kim S, Suh K, Sul J, Song I, Kim Y, Lee C.

World J Surg. 2009 May;33(5):943-9. doi: 10.1007/s00268-009-9955-z.

PMID:
19259728
17.

Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.

Taira N, Ohsumi S, Takabatake D, Hara F, Takashima S, Aogi K, Takashima S, Inoue T, Sugata S, Nishimura R.

Jpn J Clin Oncol. 2009 Jan;39(1):16-21. doi: 10.1093/jjco/hyn120. Epub 2008 Nov 8.

PMID:
18997183
18.

Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.

Sürücü E, Polack BD, Demir Y, Durmuşoğlu M, Ekmekçi S, Sarıoğlu S, Çelik AO, Ada E, İkiz AÖ.

Clin Imaging. 2015 Sep-Oct;39(5):781-6. doi: 10.1016/j.clinimag.2015.02.004. Epub 2015 Feb 12.

PMID:
25721710
19.
20.

The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.

Lu P, Sun Y, Sun Y, Yu L.

Lung Cancer. 2014 Jul;85(1):53-8. doi: 10.1016/j.lungcan.2014.04.004. Epub 2014 Apr 18.

PMID:
24792334

Supplemental Content

Support Center